100% Same
Salt CompositionEffectivenessStrength
with Substitute Medicine
Salt Composition in bothYou Searched
Our Recommendation
WHO GMP
Certified
15 Days Easy
Returns
Long Expiry
(>8 Months)
WHO GMP
Certified
15 Days Easy
Returns
Long Expiry
(>8 Months)
Delivery by
Uses of Moncitra Plus 75 mg/5 mg/10 mg Tablet
Treatment of Respiratory tract disorders associated with viscid mucus
Customers also bought
More About Moncitra Plus 75 mg/5 mg/10 mg Tablet
Benefits
Side Effects
The majority of side effects typically do not necessitate medical intervention. and disappear as your body adjusts to the medicine. Doctor consultation is advised if they persist or if you're worried about them.
How to use
Follow your doctor's guidance regarding the dose and duration of this medication. Ingest it without breaking or crushing. Do not chew, crush or break it. Moncitra Plus 75 mg/5 mg/10 mg Tablet can be taken it with or without food, although it's advisable to take it consistently at the same time.
How it works
Moncitra Plus 75 mg/5 mg/10 mg Tablet is a combination of three medicines: Ambroxol, Levocetirizine and Montelukast. Ambroxol is a mucolytic which thins and loosens mucus (phlegm), making it easier to cough out. Levocetirizine is an antiallergic which relieves allergy symptoms like runny nose, watery eyes and sneezing. Montelukast is a leukotriene antagonist. It works by blocking the action of leukotriene, a chemical messenger. This reduces inflammation in the airways and nose and improves your symptoms.
Caution: It is important to consult your doctor regarding alcohol consumption while taking Moncitra Plus 75 mg/5 mg/10 mg Tablet .
Seek medical advice from your doctor: Moncitra Plus 75 mg/5 mg/10 mg Tablet may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Doctor consultation is advised.
Seek medical advice from your doctor: Moncitra Plus 75 mg/5 mg/10 mg Tablet is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Not Safe: Moncitra Plus 75 mg/5 mg/10 mg Tablet may decrease alertness, affect your vision or make you feel sleepy and dizzy. Do not drive if these symptoms occur.
Caution Advised: Moncitra Plus 75 mg/5 mg/10 mg Tablet should be used with caution in patients with kidney disease. Dose adjustment of Moncitra Plus 75 mg/5 mg/10 mg Tablet may be needed. Doctor consultation is advised. Use of Moncitra Plus 75 mg/5 mg/10 mg Tablet is not recommended in patients with severe kidney disease.
Caution Advised: Moncitra Plus 75 mg/5 mg/10 mg Tablet should be used with caution in patients with liver disease. Dose adjustment of Moncitra Plus 75 mg/5 mg/10 mg Tablet may be needed. Doctor consultation is advised.
What if I forget to take it?
If a dose of Moncitra Plus 75 mg/5 mg/10 mg Tablet is missed, take it promptly. However, if your next dose is approaching, skip the missed dose and resume your regular schedule. Avoid doubling the dose.
Manufacturer Address
Tablets (India) Limited, 'Jhaver Centre', 72 Marshalls Road, Chennai 600 008.
References
Disclaimer
PlatinumRx is dedicated to delivering dependable and trustworthy information to empower our customers. However, the information presented here is solely for general informational purposes and should not be utilized for diagnosing, preventing, or treating health issues. It is not intended to establish a doctor-patient relationship or serve as a substitute for professional medical advice.
More Medicines By Manufacturer
More Medicines With Salt
Top Selling Medicines
Top Selling Devices
Flat ₹100 off on first app order | Use Code: APP100 |
Flat ₹100 off on first app order
USE CODE: APP100
Download Now
